Literature DB >> 9641386

Long-term results of 630 thoracoscopic sympathicotomies for primary hyperhidrosis: the Vienna experience.

J Zacherl1, E R Huber, M Imhof, E G Plas, F Herbst, R Függer.   

Abstract

OBJECTIVE: To evaluate of the results of thoracoscopic sympathicotomy for upper limb hyperhidrosis with a median observation period of more than 15 years.
DESIGN: Retrospective clinical observation study.
SETTING: University-affiliated tertiary referral centre.
SUBJECTS: 630 consecutive operations in 352 patients (median age 30.1 yrs) for primary palmar (68%), axillary (12.7%) and combined hyperhidrosis (19.3%).
INTERVENTIONS: Thoracoscopic sympathicotomy from below T1 to T4 including the fibres of Kuntz using electrocautery through single site access. MAIN OUTCOME MEASURES: Perioperative success and complication rates (all patients); long-term follow-up by a questionnaire and/or clinical examination (83.3% of patients) after a median period of 16 yrs. Calculation of statistical significance of differences between groups with c2-test.
RESULTS: 67.8% of patients were fully satisfied, 25.7% were partially satisfied and would again agree to the operation. In 93% the procedure cured hyperhidrosis permanently. Compensatory and gustatory sweating was observed in 67% and 47% of cases, respectively. Overall success was significantly (p < 0.001) lower in the group with axillary hyperhidrosis. Main complications: drainage for pneumothorax 1.3%, Horner's syndrome in 3.8%, subcutaneous emphysema 2.1%.
CONCLUSION: Thoracoscopic sympathicotomy proved to be highly effective even after long-term follow-up. Compensatory sweating impairs patients' satisfaction in some cases.

Entities:  

Mesh:

Year:  1998        PMID: 9641386     DOI: 10.1080/11024159850191148

Source DB:  PubMed          Journal:  Eur J Surg Suppl        ISSN: 1102-416X


  15 in total

Review 1.  Thoracoscopic sympathectomy for palmar hyperhidrosis. Ablate or resect?

Authors:  M Hashmonai; A Assalia; D Kopelman
Journal:  Surg Endosc       Date:  2001-04-03       Impact factor: 4.584

2.  Thoracic sympathicolysis for primary hyperhidrosis: a review of 918 procedures.

Authors:  J Moya; R Ramos; R Morera; R Villalonga; V Perna; I Macia; G Ferrer
Journal:  Surg Endosc       Date:  2006-01-25       Impact factor: 4.584

3.  [Treatment of palmar and axillary hyperhidrosis: thoracoscopic resection of the sympathetic chain].

Authors:  R Rieger; S Pedevilla; S Pöchlauer
Journal:  Chirurg       Date:  2008-12       Impact factor: 0.955

4.  Intraoperative prediction of compensatory sweating for thoracic sympathectomy.

Authors:  Takeo Fujita; Masayuki Mano; Hideyuki Nishi; Nobuyoshi Shimizu
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2005-09

5.  Do children tolerate thoracoscopic sympathectomy better than adults?

Authors:  Zvi Steiner; Zahavi Cohen; Oleg Kleiner; Ibrahim Matar; Jorge Mogilner
Journal:  Pediatr Surg Int       Date:  2007-11-13       Impact factor: 1.827

6.  Long-term results of a randomized controlled trial of T2 versus T2-T3 ablation in endoscopic thoracic sympathectomy for palmar hyperhidrosis.

Authors:  Wilson Ong; Alvin Lee; Wee Boon Tan; Davide Lomanto
Journal:  Surg Endosc       Date:  2015-07-07       Impact factor: 4.584

7.  Long-term results of endoscopic sympathetic block using the Lin-Telaranta classification.

Authors:  Tuomo Rantanen; Timo Telaranta
Journal:  Surg Endosc       Date:  2013-05-25       Impact factor: 4.584

Review 8.  The correlation between the method of sympathetic ablation for palmar hyperhidrosis and the occurrence of compensatory hyperhidrosis: a review.

Authors:  Doron Kopelman; Moshe Hashmonai
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

Review 9.  Evidence for effectiveness of botulinum toxin for hyperhidrosis.

Authors:  R Bhidayasiri; D D Truong
Journal:  J Neural Transm (Vienna)       Date:  2007-09-21       Impact factor: 3.575

10.  Endoscopic thoracic sympathectomy for hyperhidrosis: Technique and results.

Authors:  C S Cinà; M M Cinà; C M Clase
Journal:  J Minim Access Surg       Date:  2007-10       Impact factor: 1.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.